GlassScriptPhysician profile
Nanette C Vela
NPI 1194230714
$3,111.05
in general payments reported to CMS, 2019-2025
17 companies · $1,039 in 2025
The $1,039 reported for 2025 was more than what 86% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $728 · 2022: $918 · 2023: $202 · 2024: $225 · 2025: $1,039.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,465.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,465.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,491.68 | 2021-2025 | Interstim, Selectsecure, Azure Xt Dr Mri Surescan |
| Philips North America LLC | $538.36 | 2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Palette Life Sciences, INC. | $151.31 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $142.28 | 2025 | Farxiga |
| Novo Nordisk INC | $129.16 | 2025 | Wegovy |
| Teleflex LLC | $123.69 | 2021 | |
| Boston Scientific Corporation | $108.78 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $95.75 | 2024-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $81.27 | 2024-2025 | Verquvo |
| Amgen INC. | $60.47 | 2024-2025 | Repatha, Repatha |
| Abiomed | $54.66 | 2025 | |
| 180 Medical, INC. | $43.94 | 2022 | |
| Endo Pharmaceuticals INC. | $21.48 | 2022 | |
| Lilly USA, LLC | $21.21 | 2025 | Zepbound, Mounjaro |
| Astellas Pharma US INC | $17.04 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.04 | 2024 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $14.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nanette Vela listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.